Status:

COMPLETED

Cytokine Induced Killer (CIK) Cells In Leukemia Patients

Lead Sponsor:

A.O. Ospedale Papa Giovanni XXIII

Collaborating Sponsors:

Regional Hospital of Bolzano

Azienda Ospedaliera San Gerardo di Monza

Conditions:

Hematologic Malignancies

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

The purpose of the Phase IIA study are to: 1. define the safety profile 2. evaluate the efficacy of a sequential infusion of unmanipulated Donor Lymphocyte Infusions (DLI) and Cytokine Induced Killer...

Detailed Description

This study is an open-label, multicenter, exploratory phase IIA study to evaluate the safety (dose-finding) and efficacy of a sequential administration of donor derived unmanipulated DLI and in vitro ...

Eligibility Criteria

Inclusion

  • Patients with haematologic malignancies (excluding chronic myeloid Leukemia- CML) with a molecular, cytogenetic or haematologic relapse after allogeneic transplantation.
  • Patients with an available donor willing to donate peripheral blood lymphocytes
  • Immunosuppression must be withdrawn at the beginning of the cell therapy program
  • Written informed consent prior to any study procedures being performed

Exclusion

  • Donors positive for HIV, HBV or HCV, or unfit to undergo leukapheresis
  • Patients with active acute or chronic Graft versus host disease (GvHD)
  • Patients with rapidly progressive disease or not controlled by palliative supportive treatments including chemotherapy and with a life expectancy less than 8 weeks
  • Patients with severe psychiatric illness or any disorder that compromises ability to give truly informed consent for participation in this study

Key Trial Info

Start Date :

July 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 15 2017

Estimated Enrollment :

74 Patients enrolled

Trial Details

Trial ID

NCT01186809

Start Date

July 1 2009

End Date

May 15 2017

Last Update

January 23 2019

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Azienda Ospedaliera Papa Giovanni XXIII (Former:Ospedali Riuniti di Bergamo) Bergamo

Bergamo, Italy, 24127

2

Ospedale Centrale di Bolzano

Bolzano, Italy

3

Ospedale San Gerardo

Monza, Italy

Cytokine Induced Killer (CIK) Cells In Leukemia Patients | DecenTrialz